MedComm – Oncology

Metadata for this journal is being automatically enriched from connected scholarly data sources.

Journal information

Publisher

Wiley

Subjects

cancer · cancer biomarkers · Cancer Cells and Metastasis · Cancer Immunotherapy and Biomarkers · cancer metabolism · Cancer Research and Treatments · Cancer, Hypoxia, and Metabolism · Epigenetics and DNA Methylation · Ferroptosis and cancer prognosis · gene therapy · immunotherapy · Nanoplatforms for cancer theranostics · Neoplasms. Tumors. Oncology. Including cancer and carcinogens · RC254-282 · RNA modifications and cancer

Country

AU

Languages

EN

ISSN

2769-6448

E-ISSN

2769-6448

ISSN-L

2769-6448

Open access

Yes

OA since

2022

Publication years

2022–2026

APC (summary)

—

Website

Visit journal ↗

Journal Classification

Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.

Classification

Field / Subfield

Primary Field

Medicine

Primary Subfield

Oncology

Domain

Health Sciences

Confidence

Medium

Publications classified

87

Classification version

OAJF Classification v1.1

APC records

OPENALEX · 2026

0 USD

DOAJ · 2026

2,490 EUR

DOAJ · 2026

2,160 GBP

DOAJ · 2026

2,600 USD